Glyburide (Compound)

Synonyms:glyburide, Glibenclamide, 10238-21-8, Glybenclamide, Glynase, Diabeta, Micronase, Daonil, Euglucon, Maninil, Glybenzcyclamide, Semi-daonil, Apo-Glibenclamide, Euglucon 5, Azuglucon, Bastiverit, Benclamin, Betanase, Duraglucon, Euglucan, Euglykon, Glibenil, Glucolon, Orabetic, Prodiabet, Renabetic, Yuglucon, Dibelet, Gilemal, Glibens, Glibil, Glimel, Glimide, Humedia, Libanil, Suraben, Tiabet, Adiab, Melix, Pira, Med-Glionil, Glibenclamidum, Glibenclamida, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide, HB 419, Glibenclamidum [INN-Latin], Glibenclamida [INN-Spanish], C23H28ClN3O5S, glyburide (glibenclamide), HB-419, UR 606, Cirara, 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea, 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea, Neogluconin, 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide, 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide, Glibenclamide [INN], U 26452, Gewaglucon, Glibenbeta, Glidiabet, Glucobene, Glucohexal, Glucoremed, Hexaglucon, Lederglib, Lisaglucon, Normoglucon, Praeciglucon, Calabren, Cytagon, Euclamin, Glamide, Glibesyn, Glibetic, Gliboral, Glisulin, Glitisol, Glubate, Glucomid, Glucoven, Glycomin, Miglucan, Debtan, Gliban, Gliben, Glibet, Glicem, Gluben, Glyben, Nadib, Sugril, SX6K58TVWC, CHEMBL472, Novo-Glyburide, NSC-759618, Glibenclamid AL, 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, Gen-Glybe, Norglicem 5, Betanese 5, N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea, Glibenclamid Fabra, 5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide, Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-, MLS000069721, CHEBI:5441, Glibenclamid Basics, Glibenclamid-Cophar, DTXSID0037237, Glibenclamid Heumann, Semi-Euglucon, Glibenclamid Genericon, Hemi-Daonil, U-26452, Glibenclamid-Ratiopharm, U-26,452, Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-, Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-, Glyburide [USAN], NCGC00015467-11, Abbenclamide, Diabiphage, Glibadone, SMR000058229, Semi-Gliben-Puren N, GBN 5, CAS-10238-21-8, Glibenclamid Riker M., Glyburide (micronized), Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-, U-26,45, Micronized glyburide, DTXCID8017237, Glycron, 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea, 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, 5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)-phenethyl)-2-methoxybenzamide, Glyburide (USP), Micronase (TN), 1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea;1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea, Diabeta (TN), Glynase (TN), SR-01000000196, Glyburide [USAN:USP], EINECS 233-570-6, UNII-SX6K58TVWC, BRN 2230085, Amglidia, Delmide, 5-chloro-N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-methoxybenzamide, Glibenclamide,(S), GBM, Prestwick_569, Glibenclamide B.P., MFCD00056625, RP-1127, Spectrum_000250, Tocris-0911, Glibenclamide - Bio-X, Glybenzcyclamide, 99%, Opera_ID_801, GLYBURIDE [MI], Prestwick0_000316, Prestwick1_000316, Prestwick2_000316, Prestwick3_000316, Spectrum2_001816, Spectrum3_001327, Spectrum4_001199, Spectrum5_001631, GLYBURIDE [VANDF], Lopac-G-0639, Probes1_000431, Probes2_000378, UPCMLD-DP006, G 0639, GLIBENCLAMIDE [JAN], N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea, GLYBURIDE [USP-RS], GLYBURIDE [WHO-IP], Glibenclamide (JP17/INN), N-(4-(beta-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, CBiol_001790, Lopac0_000499, Oprea1_764617, SCHEMBL22009, BSPBio_000312, BSPBio_001351, BSPBio_003053, KBioGR_000071, KBioGR_001897, KBioSS_000071, KBioSS_000730, MLS001077262, BIDD:GT0239, DivK1c_000481, GLIBENCLAMIDE [MART.], SPECTRUM2300229, SPBio_001831, SPBio_002531, GLIBENCLAMIDE [WHO-DD], GLIBENCLAMIDE [WHO-IP], BPBio1_000344, GTPL2414, GLYBURIDE [ORANGE BOOK], UPCMLD-DP006:001, HMS501I03, KBio1_000481, KBio2_000071, KBio2_000730, KBio2_002639, KBio2_003298, KBio2_005207, KBio2_005866, KBio3_000141, KBio3_000142, KBio3_002273, GLYBURIDE [USP MONOGRAPH], Glybenclamide, >=99% (HPLC), NINDS_000481, Bio1_000076, Bio1_000565, Bio1_001054, Bio2_000071, Bio2_000551, HMS1361D13, HMS1568P14, HMS1791D13, HMS1922L08, HMS1989D13, HMS2089L06, HMS2093P04, HMS2095P14, HMS3259O12, HMS3261D19, HMS3267A15, HMS3402D13, HMS3411F16, HMS3428D15, HMS3651E17, HMS3675F16, HMS3712P14, Pharmakon1600-02300229, BCP05327, GLIBENCLAMIDE [EP MONOGRAPH], Glibenclamide for peak identification, Tox21_110158, Tox21_300758, Tox21_500499, BDBM50012957, CCG-39618, GLUCOVANCE COMPONENT GLYBURIDE, HD 419, NSC759618, NSC813214, STK362992, GLIBENCLAMIDUM [WHO-IP LATIN], Glyburide - CAS 10238-21-8, AKOS001487495, Tox21_110158_1, BCP9000729, CS-1075, DB01016, KS-5326, LP00499, NC00566, NSC 759618, NSC-813214, SB17414, SDCCGSBI-0050483.P004, GLYBURIDE COMPONENT OF GLUCOVANCE, IDI1_000481, IDI1_033821, Glibenclamide 1.0 mg/ml in Acetonitrile, NCGC00015467-01, NCGC00015467-02, NCGC00015467-03, NCGC00015467-04, NCGC00015467-05, NCGC00015467-06, NCGC00015467-07, NCGC00015467-08, NCGC00015467-09, NCGC00015467-10, NCGC00015467-12, NCGC00015467-13, NCGC00015467-14, NCGC00015467-15, NCGC00015467-16, NCGC00015467-17, NCGC00015467-18, NCGC00015467-20, NCGC00015467-21, NCGC00015467-36, NCGC00015467-37, NCGC00016689-01, NCGC00023447-02, NCGC00023447-04, NCGC00023447-05, NCGC00023447-06, NCGC00023447-07, NCGC00023447-08, NCGC00023447-09, NCGC00023447-10, NCGC00023447-11, NCGC00023447-12, NCGC00254662-01, NCGC00261184-01, BG166164, HY-15206, SBI-0050483.P003, Glyburide, meets USP testing specifications, AB00051949, EU-0100499, FT-0601608, G-150, G0382, S1716, SW195828-5, A19539, C07022, D00336, D81733, EN300-117270, M01823, AB00051949-16, AB00051949-17, AB00051949_18, AB00051949_19, Q420626, SR-01000000196-2, SR-01000000196-4, SR-01000000196-5, SR-01000000196-6, SR-01000000196-8, W-108874, BRD-K36927236-001-06-0, BRD-K36927236-001-17-7, Z277540138, Glybenclamide, European Pharmacopoeia (EP) Reference Standard, Glyburide, United States Pharmacopeia (USP) Reference Standard, 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl urea, 5-Chloro-N-[4-(3-cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide., 5-chloro-N-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-2-methoxybenzamide, Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard, Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material, N-(4-(.beta.-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, N1-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-5-chloro-2-methoxybenzamide, 5-Chloro-N-(2-[4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-2-methoxybenzamide #, 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide, 5-Chloro-N-[2-[4-[[[(Cylcohexylamino)carbonyl]amino]sulphonyl]phenyl]ethyl]-2-methoxybenzamide

Id:3488

Description:nan